Navigation Links
Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhancement Award
Date:12/1/2008

MOUNTAIN VIEW, Calif., Dec. 1 /PRNewswire/ -- This week Frost & Sullivan announced that Martek Biosciences Corporation, creator of the fast-growing life'sDHA(TM) brand of DHA (docosahexaenoic acid), is the 2008 recipient of the North American Frost & Sullivan Customer Value Enhancement Award. This award is in recognition of Martek's long-standing, successful customer relationships and innovative marketing and branding initiatives that have helped to establish the company as a leading global provider of DHA omega-3 products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )

Martek's solid research pipeline along with strategic alliances and a strong intellectual property strategy has further cemented its superiority in the market. Martek has developed a strong intellectual property position globally by strategically developing multiple layers of patent protection. Martek's patent portfolio includes more than 700 granted patents and pending applications worldwide. Its strong patent portfolio has ensured that it is the only source of DHA and ARA used in infant formula sold in the United States.

"The company has successfully established significant and long-term supply agreements and has capitalized on its strength of being a leading supplier of vegetarian DHA and arachidonic acid (ARA)," notes Frost & Sullivan Research Analyst Arthi V. "Martek has signed multi-year sole supplier agreements with a number of leading infant formula manufacturers to further strengthen its relationships with key customers."

Martek has also focused on comprehensive marketing initiatives, making extensive use of various media and consumer outreach strategies to promote its brand, life'sDHA. This has led to double digit growth in consumer awareness of the life'sDHA brand since the brand was launched in 2006. As a result, Martek is one of the few companies providing high-value nutritional products to successfully secure a brand presence through the appearance of its life'sDHA logo on numerous consumer packaged goods that are household names.

life'sDHA is derived directly from microalgae, a renewable, sustainable source of DHA that does not deplete ocean resources and is produced entirely in the U.S. in a FDA-inspected facility. Today, life'sDHA is a trusted source of DHA omega-3 found in numerous foods, beverages and supplements for people of all ages. It is also the only source of DHA used in U.S. infant formula and is included in more than 99 percent of all formulas on the U.S. market. In addition, life'sDHA is found in more than 200 brands of infant formula, nutritional supplements and functional foods sold in over 75 countries worldwide. Martek has received approvals for the use of life'sDHA in wide range of foods and supplements in Europe, Australia/New Zealand, and Canada.

"life'sDHA has exceptional sensory characteristics; it does not adversely affect a product's sensory properties such as taste or odor," says Arthi. "It also has an outstanding shelf life and is highly concentrated, so less is needed."

Martek's innovation and experience in the production, refinement and formulation of high quality DHA omega-3 products has established it as a leader in customer value enhancement. Martek develops close working relationships with its customers and provides personalized technical support to ensure the highest quality finished products by offering a range of services, including an experimental food development laboratory, small-scale food production capabilities, sensory analysis and chemical analytical support.

This has resulted in exceptional customer retention and a rapidly growing customer base. This year, Martek announced the launch of the 100th food and beverage product incorporating life'sDHA. The ingredient was first introduced in soy beverages, yogurt and yogurt drinks in 2006, and the range of products into which life'sDHA has been added now includes milk, fruit juices, baby foods, sushi, nutrition bars and cheese. This year alone, the brand expanded further into cooking oils, bread, butter, frozen foods, smoothies, meat, meat alternatives and more. In addition, many of Martek's customers continue to introduce follow-on products based on the success of their initial product launches.

Each year, Frost & Sullivan presents this award to the company that has best demonstrated the ability to expand its customer base, while maintaining its existing customer base, with more innovative value creation and enhancement strategies than competing vendors. This Award recognizes the company's successful sales entry, customer acquisition and service strategies, and the degree to which those strategies have met customers' stated needs and requirements. Such strategies are expected to significantly improve customer interaction and contribute to their satisfaction.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Martek Biosciences Corporation

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA, a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula, and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/. For a complete list of life'sDHA products, visit http://www.lifesdha.com/.

About Frost & Sullivan

Frost &Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visithttp://www.awards.frost.com.

    Contact:
    Jake Wengroff
    210.247.3806
    jake.wengroff@frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
2. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
3. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
4. Signalife Wins Second Frost & Sullivan Technology Award
5. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
6. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
7. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
8. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
(Date:10/9/2017)... , ... October 09, 2017 , ... ... four-tiered line of medical marijuana products targeting the needs of consumers who are ... of Kindred takes place in Phoenix, Arizona. , As operators of two successful ...
Breaking Biology Technology:
(Date:5/6/2017)... RAM Group , Singaporean based ... in biometric authentication based on a novel  ... to perform biometric authentication. These new sensors are based on ... Ram Group and its partners. This sensor will have ... and security. Ram Group is a next generation ...
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):